A study found that reducing the dose of pembrolizumab in patients with advanced stage non–small cell lung cancer did not ...
COPENHAGEN, Denmark I September 16, 2024 I Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing ...
One of your patients might be eligible to enroll in a clinical trial currently recruiting people with breast cancer.